Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine  Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 27, 61-75, January 1, 1967]
© 1967 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Philips, F. S.
Right arrow Articles by Vidal, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Philips, F. S.
Right arrow Articles by Vidal, P. M.

Hydroxyurea

I. Acute Cell Death in Proliferating Tissues in Rats1

Frederick S. Philips2, Stephen S. Sternberg, Herbert S. Schwartz, Alice P. Cronin, Jane E. Sodergren and Pedro M. Vidal

Division of Experimental Chemotherapy, Sloan-Kettering Institute for Cancer Research, New York, New York

Hydroxyurea induces karyorrhexis in intestinal crypts, bone marrow, and germinal centers of all lymphoid tissues within a few hr after injection. Acute, selective cytotoxic effects are limited to those tissues with high rates of cellular proliferation. The pathologic process is of short duration, and repair of tissue damage is rapid. Other hydroxamic acid derivatives induce similar lesions: N-hydroxyurethan, acetohydroxamic acid, N,O-diacetyl-N-methylhydroxylamine, and 1-methyl- and 1-ethyl-1-hydroxyurea. The lesions are not seen in rats given hydroxylamine or N-methylhydroxylamine.

The cytotoxic effects are related in time to the physiologic disposition of hydroxyurea. The agent is rapidly equilibrated throughout body water. Its concentration in plasma decays exponentially with half-lives of 65 min at levels above 150 µg/ml and of 35 min below 100 µg/ml. N-Hydroxyurethan and acetohydroxamic acid are disposed of in vivo at comparable rates. All 3 substances are excreted unchanged in urine and are also extensively metabolized. The close temporal relation between the build-up and repair of cytotoxic changes and the physiologic disposition suggests that the proximal biochemical defect produced by the hydroxamates is reversible.

Hydroxyurea induces an immediate inhibition of thymidine incorporation into the DNA of thymus and small intestine in rats. The inhibition is reversible; its duration varies directly with the dose of hydroxyurea. From information about tissue concentrations it can be concluded that the sensitivity of thymidine incorporation in intestine and thymus in vivo is close to that of HeLa cells in culture. The cytotoxic potency of hydroxyurea, N-hydroxyurethan, and acetohydroxamic acid in intact rats is in proportion to their relative activity in inhibiting thymidine incorporation in HeLa cells. It is concluded that the lethal effects of the hydroxamates are restricted to cells committed to DNA synthesis. Other cells in proliferating tissues escape damage during the limited time of circulation of inhibitory concentrations; this accounts for the prompt repair of tissue defects.

1 Aided by Grants CA-03192 and CA-08748 from the National Cancer Institute, USPHS.

2 Visiting Investigator, Chester Beatty Research Institute, London, September, 1965-July, 1966. during tenure of an Alfred P. Sloan Award in Cancer Research.

Received 6/15/66. Accepted 7/21/66.




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
S. Bihorel, G. Camenisch, G. Gross, M. Lemaire, and J.-M. Scherrmann
Influence of Hydroxyurea On Imatinib Mesylate (Gleevec) Transport at the Mouse Blood-Brain Barrier
Drug Metab. Dispos., December 1, 2006; 34(12): 1945 - 1949.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. K. Nilsson, M. S. Dooner, and P. J. Quesenberry
Synchronized Cell-Cycle Induction of Engrafting Long-Term Repopulating Stem Cells
Blood, December 1, 1997; 90(11): 4646 - 4650.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1967 by the American Association for Cancer Research.